Mar 14, 2025, 08:09 AM by

Building on its reputation for fostering breakthrough approaches to precision medicine, the 24th annual Bio-IT World Conference & Expo, April 2-4 in Boston, will feature a plenary keynote program of distinguished biotech, pharmaceutical, and healthcare leaders who are harnessing new technologies to push therapeutic boundaries.

Mar 13, 2025, 08:17 AM by

ClearNote Health announced an agreement with Claritev, Inc., (previously MultiPlan, Inc.) that will make ClearNote Health’s Avantect Pancreatic Cancer Test available to health plan members accessing Claritev’s national PHCS and MultiPlan Networks.

Mar 13, 2025, 08:17 AM by

Watson-Marlow Fluid Technology Solutions(WMFTS) will reveal its new WMArchitect Interchangeable Parts service as well as showcase new sustainability benefits for its users from advancements in BioClamp manufacturing at booth 2753 during INTERPHEX 2025, held from April 1st-3rd at the Javits Center in NYC, USA.

Mar 13, 2025, 08:17 AM by

Mar 13, 2025, 08:17 AM by

I’m reaching out from Zymo Research to share our latest press release highlighting our commitment to American manufacturing. With the majority of our products—including key components and materials—designed, manufactured, and assembled in Southern California, we are dedicated to delivering high-quality, reliable solutions to researchers worldwide. Given your focus on [Relevant Industry/Fields], we believe this announcement will be of great interest to your audience. Our USA-based operations not only ensure stringent quality control and supply chain stability but also allow us to maintain consistent pricing, even amidst evolving trade conditions.

Mar 13, 2025, 08:17 AM by

Mar 13, 2025, 01:00 AM by User Not Found

Bio-IT World| Scientists at the University of Wisconsin – Madison believe it could soon be possible to use people’s own blood clots to treat bone-on-bone osteoarthritis by having the material be the scaffolding that fills the space where cushioning cartilage used to be. The plan is to have the clots serve as a temporary matrix that cells will infiltrate to be exposed to a gene that encourages them to form hyaline cartilage.

Mar 12, 2025, 08:34 AM by

Lindus Health and Sooma Medical announce pivotal device clinical trial for treatment of MDD

Mar 12, 2025, 08:34 AM by

Qureight Ltd. and Remedy Cell are integrating the latest AI deep learning technology into a Phase 1b study of RC-0315, to develop a novel therapy for the fatal lung condition Idiopathic Pulmonary Fibrosis (IPF).

Mar 12, 2025, 01:00 AM by User Not Found

Bio-IT World| At a session in the Cybersecurity Pavilion of ViVE last month, Cormac Miller, President and CCO of Censinet, presented the company’s 2025 cybersecurity benchmark for the healthcare sector. This year’s benchmark revealed that for the third year in a row, organizations are focusing on respond and recover capabilities.

Mar 11, 2025, 08:12 AM by

Mar 11, 2025, 01:00 AM by User Not Found

Bio-IT World| Altitude Lab, the nonprofit formed by clinical-stage biotech company Recursion, recently launched a pre-seed venture fund to help 10 to 15 early-stage startups get through the current “period of uncertainty” around government funding—and other private investment groups will ideally follow suit over the short term.

Mar 6, 2025, 08:08 AM by

Genome Canada and Oxford Nanopore Technologies announced a collaboration aimed at significantly enhancing genomics research across Canada.

Mar 6, 2025, 01:00 AM by User Not Found

Bio-IT World| A groundbreaking collaborative effort spanning 12 European countries and Canada has successfully identified genetic causes for more than 500 previously unsolved rare disease cases. Led by the University of Tübingen in Germany, the Solve-RD (Solving the Unsolved Rare Diseases) consortium brought together 300 experts from 37 institutions to leverage advanced genomic reanalysis techniques, ultimately providing long-awaited answers to patients and their families.

Mar 5, 2025, 08:14 AM by

Today, in partnership with ScienceMachine, FutureHouse is introducing BixBench, a benchmark designed to evaluate AI agents on real-world bioinformatics tasks. BixBench challenges AI models with open-ended analytical research scenarios, requiring them to analyze data, generate insights, and interpret results autonomously.

Mar 5, 2025, 08:14 AM by

Mural Health Technologies, Inc., a patient-first clinical trial technology company, and ICON plc (NASDAQ: ICLR), a global healthcare intelligence and clinical research organization, today announce a partnership to utilize the participant management and payments platform, Mural Link.

Mar 5, 2025, 01:00 AM by User Not Found

Bio-IT World| In an era where artificial intelligence (AI) dominates discussions in technology, high-performance computing (HPC) remains the backbone of scientific discovery and enterprise research. Despite its critical role, HPC often operates in the background, much like electricity—only noticed when it fails. On the latest Trends from the Trenches Podcast, Dirk Petersen, Director of the Supercomputing Center at Oregon State University, shared his insights on the evolving role of HPC and its integration into AI-driven research.

Mar 4, 2025, 01:00 AM by User Not Found

Bio-IT World| Researchers have trained an artificial intelligence (AI) model to reconstruct the electrical signals inside of heart cells based on recordings taken from outside those cells, opening the possibility of cheap, high-yielding cardiotoxicity testing using commercially available microelectrode arrays. The hope is that the U.S. Food and Drug Administration (FDA) will allow the tool to be used in lieu of inserting pipettes into cells to record signaling changes with the addition of a drug, which is both costly and cumbersome to do at scale.

Feb 28, 2025, 08:10 AM by

Owkin, a pioneer in Agentic AI for decoding the complexities of biology, has launched a comprehensive multimodal patient data discovery program to accelerate multimodal data access and advance medical research.

Feb 28, 2025, 01:00 AM by User Not Found

Bio-IT World| The rate of evolution of DNA sequencing technologies since the introduction of the Sanger method in the 1970s has been astounding. It’s just over 20 years since the publication of the first draft human genome and today, technologies can deliver that same information for as little as $100.